nad has been researched along with 5-nitro-2-(2-phenylchroman-6-yloxy)pyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acsai, K; Ágoston, S; Kormos, A; Levijoki, J; Nagy, N; Papp, JG; Pollesello, P; Szentandrássy, N; Tóth, A; Váczi, K; Varró, A | 1 |
1 other study(ies) available for nad and 5-nitro-2-(2-phenylchroman-6-yloxy)pyridine
Article | Year |
---|---|
Efficacy of selective NCX inhibition by ORM-10103 during simulated ischemia/reperfusion.
Topics: Action Potentials; Animals; Benzopyrans; Calcium; Cell Survival; Dogs; Female; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; NAD; Pyridines; Sodium-Calcium Exchanger | 2014 |